Vineet Laboratories Ltd

NSE: VINEETLAB · BSE: 543298 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹37.87
Market cap: ₹72.73 Cr
Revenue (annual): ₹59.40 Cr
Net profit (annual): ₹1.11 Cr
P/E (TTM): 20.8×Sector 43.8×
Promoter holding: 5.98%+0.00% QoQ
FII holding: 0.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

12 Nov 2026 18:09 IST NSE

Financial Results

Vineet Laboratories Q2 FY27 Results: Net Profit ₹0.1 Cr, Down 75.0% YoY

Vineet Laboratories Ltd reported revenue from operations of ₹14.2 Cr (-18.4% YoY) and net profit of ₹0.1 Cr (-75.0% YoY) for Q2 FY27.

Key figure: Net profit ₹0.1 Cr · -75.0% YoY

Open full results → Read the filing ↗

7 Nov 2026 16:12 IST BSE

Annual Report

Vineet Laboratories Annual Report

Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.

Open announcement → Read the filing ↗

7 Nov 2026 16:06 IST NSE

Annual General Meeting

Vineet Laboratories Annual General Meeting

Vineet Laboratories has circulated notice of its 10th AGM, scheduled for 30 November 2026 via video conferencing. The filing attaches the FY 2025-26 annual report.

Open announcement → Read the filing ↗